Page 111 - Read Online
P. 111
Page 16 of 16 Cadamuro et al. Hepatoma Res 2022;8:11 https://dx.doi.org/10.20517/2394-5079.2021.140
117. Moeini A, Sia D, Zhang Z, et al. Mixed hepatocellular cholangiocarcinoma tumors: Cholangiolocellular carcinoma is a distinct
molecular entity. J Hepatol 2017;66:952-61. DOI PubMed
118. Montal R, Sia D, Montironi C, et al. Molecular classification and therapeutic targets in extrahepatic cholangiocarcinoma. J Hepatol
2020;73:315-27. DOI PubMed PMC
119. Affo S, Nair A, Brundu F, et al. Promotion of cholangiocarcinoma growth by diverse cancer-associated fibroblast subpopulations.
Cancer Cell 2021;39:866-882.e11. DOI PubMed PMC
120. Su M, Qiao KY, Xie XL, et al. Development of a prognostic signature based on single-cell RNA sequencing data of immune cells in
intrahepatic cholangiocarcinoma. Front Genet 2020;11:615680. DOI PubMed PMC
121. Zhang M, Yang H, Wan L, et al. Single-cell transcriptomic architecture and intercellular crosstalk of human intrahepatic
cholangiocarcinoma. J Hepatol 2020;73:1118-30. DOI PubMed
122. Carpino G, Overi D, Melandro F, et al. Matrisome analysis of intrahepatic cholangiocarcinoma unveils a peculiar cancer-associated
extracellular matrix structure. Clin Proteomics 2019;16:37. DOI PubMed PMC
